Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
agalsidase beta (Fabrazyme) (1 trial)
imiglucerase (cerezyme) (4 trials)
abciximab (Reopro) (1 trial)
cetuximab (erbitux) (1 trial)
isu104 (1 trial)
isu304 (1 trial)
Gaucher Disease (Phase 3)
Hemophilia A (Phase 1)
Hemophilia B (Phase 1)
Infarction (Phase 2)
Myocardial Infarction (Phase 2)
Neoplasms (Phase 1)
Trials (8 total)
Trial APIs (6 total)